Anticholinergic Agents In The Upper & Lower Airways. Cet article n’est pas disponible.Anticholinergic Agents In The Upper & Lower Airways

This comprehensive collection discusses anticholinergic agents, integrating the treatment of rhinitis, the common cold, and asthma in the upper and lower airways, while updating the latest therapeutic practices.
Features assessments of soon-to-be-available medications!
Written by expert allergists and pulmonologists as an exploration of the clinical application of antimuscarinics, Anticholinergic Agents in the Upper and Lower Airways

explores the common triggers and pathogenesis of the upper and lower airways, including pathogenic mechanisms that cause allergies

covers hyperresponsiveness and the M2 and M3 receptors

considers the interactions of muscarinic receptors with other substances such as protein kinase C, cytokines, and growth factors that magnify the receptors' effects

analyzes bronchodilators, bronchomotor tone, and reflex bronchospastic mechanisms

assesses antimuscarinic drugs as treatment for acute asthma attacks

reviews the use of anticholinergic agents to treat rhinorrhea and upper respiratory infections

surveys data regarding the combination of beta agonists and antimuscarinics

evaluates the future of tiotropium bromide as a bronchodilator

focuses on the subspecialties of allergy and chest medicine

examines new work regarding the interaction of viruses and the muscarinic receptor

and more!
Containing over 700 references to facilitate further study, Anticholinergic Agents in the Upper and Lower Airways is a thorough, multidisciplinary reference especially relevant to clinical immunologists and allergists, pulmonologists, physiologists, lung biologists, family and general practitioners, internists, pediatricians, and medical students in these disciplines.

This comprehensive collection discusses anticholinergic agents, integrating the treatment of rhinitis, the common cold, and asthma in the upper and lower airways, while updating the latest therapeutic practices.
Features assessments of soon-to-be-available medications!
Written by expert allergists and pulmonologists as an exploration of the clinical application of antimuscarinics, Anticholinergic Agents in the Upper and Lower Airways

explores the common triggers and pathogenesis of the upper and lower airways, including pathogenic mechanisms that cause allergies

covers hyperresponsiveness and the M2 and M3 receptors

considers the interactions of muscarinic receptors with other substances such as protein kinase C, cytokines, and growth factors that magnify the receptors' effects

analyzes bronchodilators, bronchomotor tone, and reflex bronchospastic mechanisms

assesses antimuscarinic drugs as treatment for acute asthma attacks

reviews the use of anticholinergic agents to treat rhinorrhea and upper respiratory infections

surveys data regarding the combination of beta agonists and antimuscarinics

evaluates the future of tiotropium bromide as a bronchodilator

focuses on the subspecialties of allergy and chest medicine

examines new work regarding the interaction of viruses and the muscarinic receptor

and more!
Containing over 700 references to facilitate further study, Anticholinergic Agents in the Upper and Lower Airways is a thorough, multidisciplinary reference especially relevant to clinical immunologists and allergists, pulmonologists, physiologists, lung biologists, family and general practitioners, internists, pediatricians, and medical students in these disciplines.